Insider filing · AXSM
Nick Pizzie
Chief Financial Officer
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Nick Pizzie sold $2.0M of Axsome Therapeutics (AXSM)
Executed Feb 13 2025, disclosed Feb 14 2025, 1 day later.
Value, as filed
$2.0M
15,000 sh across 2 lots
Executed
Feb 13 2025
the trade date, as filed
Disclosed
Feb 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NPNick Pizzie (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $7.9M of AXSM (33,000 sh × $240.09, as filed), executed Jun 9.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Nick Pizzie in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$7.9M33,000 sh × $240.09
Exec Jun 9
Filed Jun 9 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $2.3M
12,000 sh × $187.92
Exec Jan 22
Filed Jan 23 · 5:30 PM ET